In 2018, I chaired a hearing of the Senate Aging Committee on why the costs of insulin was so high.
I am puzzled at the flat funding for Alzheimer's research.
I know personally what this means to American families.
In my judgment, there is no investment that pays greater dividends to American families than our investment in biomedica...
I'm so frustrated that these new therapies based on sound science approved by the FDA are not reaching patients.